Methyl aminolevulinate (Metvix®) photodynamic therapy - Practical pearls

Journal of Dermatological Treatment

Volumn 14, Issue SUPPL. 3, 2003, Pages 23-26

  Morton, C A ^a,b  

^a Ward 17 Falkirk Community Hospital   (United Kingdom)

^b Department of Dermatology ^*  (United Kingdom)

Author keywords

Methyl aminolevulinate; Non melanoma skin cancer (NMSC); Photodynamic therapy (PDT)

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; FLUOROURACIL; PHOTOSENSITIZING AGENT; PORPHYRIN; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ANALGESIA; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; BURNING SENSATION; CANCER DIAGNOSIS; CARCINOGENICITY; CLINICAL TRIAL; CREAM; DRUG EFFICACY; EDEMA; ERYTHEMA; FLUORESCENCE; HAIR LOSS; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; NON MELANOMA SKIN CANCER; NONHUMAN; PAIN; PATIENT SELECTION; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RED LIGHT; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0344441708     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/jdt.14.s3.23.26     Document Type: Article

References (15)

1. Morton CA, Brown SB, Collins S et al, Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol (2002) 146; 552-67.
2. Szeimies RM, Karrer S, Radakovic-Fijan S et al, Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol (2002) 47: 258-62.
3. Pariser DM, Lowe NJ, Stewart DM et al, Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol (2003) 48: 227-32.
4. Soler AM, Warloe T, Berner A et al, A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol (2001) 145: 467-71.
5. Basset-Seguin N, Ibbotson S, Emtestam L, Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Vener (2001) 15(S2): 226.
6. Rhodes LE et al, Photodynamic therapy using topical methyl aminolevulinate versus surgery for nodular basal cell carcinoma: results of a multicentre randomised prospective trial (In press).
7. Morton CA, Whitehurst C, McColl JH et al, Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch Dermatol (2001) 137: 319-24.
8. Kurwa HA, Yong-Gee SA, Seed PT et al, A randomized paired comparison of photodynamic therapy and 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol (1999) 41: 414-18.
9. Salim A et al, Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol (2003) 148: 539-43.
10. Peng Q, Moan J, Warloe T et al, Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B (1996) 34: 95-6.
11. Sorensen R, Juzenas P, Iani V et al, Formation of protoporphyrin IX in mouse skin after topical application of 5-aminolevulinic acid and its methyl ester. SPIE (1998) 3563: 77-81.
12. Hannuksela-Svahn A, Pukkala E, Karvonen J, Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol (1999) 135: 781-6.
13. Holme SA, Malinovszky K, Roberts DL, Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol (2000) 143: 1224-9.
14. Karagas MR, Greenberg ER, Spencer SK et al, Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer (1999) 81: 555-9.
15. Salasche SJ, Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol (2000) 42: 4-7.